Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants

BACKGROUND: The optimal treatment regimen or protocol for managing a persistent patent ductus arteriosus (PDA) in extremely low birth weight (ELBW) infants has not been well established. This study was aimed at evaluating the failure rate of a cyclooxygenase (COX) inhibitor (COI) for PDA closure and...

Descripción completa

Detalles Bibliográficos
Autores principales: Adrouche-Amrani, Lynda, Green, Robert S, Gluck, Karen M, Lin, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293740/
https://www.ncbi.nlm.nih.gov/pubmed/22284694
http://dx.doi.org/10.1186/1471-2431-12-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293740/
https://www.ncbi.nlm.nih.gov/pubmed/22284694
http://dx.doi.org/10.1186/1471-2431-12-10

Ejemplares similares